These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 26805276)

  • 1. [A Patient with Rectal Cancer and Multiple Lung Metastases Treated with XELOX plus Bevacizumab (Bev) Therapy].
    Noura S; Ohue M; Miyoshi N; Yasui M; Sugimoto N; Okami J; Higashiyama M; Fujiwara Y; Yano M; Sakon M
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):2097-9. PubMed ID: 26805276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pathological Complete Response in a Case of Multiple Liver Metastases from Rectal Cancer Treated with XELOX plus Bevacizumab(Bev)Therapy].
    Noura S; Shuto T; Muratsu A; Yoshida Y; Yasuyama A; Matsumura T; Koga C; Kameda C; Murakami M; Kawabata R; Hirota M; Yoshikawa M; Shimizu J; Hasegawa J; Miwa H
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):1742-1744. PubMed ID: 28133117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A Case of Colon Cancer with Brain, Liver and Lung Metastasis Successfully Treated with Bevacizumab plus Xelox Therapy].
    Tokoro T; Nakamura K; Hirose A; Nakanuma S; Okamoto K; Kinoshita J; Makino I; Hayashi H; Oyama K; Miyashita T; Tajima H; Takamura H; Ninomiya I; Fushida S; Ohta T
    Gan To Kagaku Ryoho; 2018 Mar; 45(3):521-523. PubMed ID: 29650925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A Case of Rectal Cancer with Multiple Liver, Lung, and Para-Aortic Lymph Node Metastases Successfully Treated with FOLFOX4 plus Bevacizumab].
    Takahashi S; Hanaka J; Takahashi M; Kanamura S; Wakamatsu T; Nakayama H; Goya T
    Gan To Kagaku Ryoho; 2015 Dec; 42(13):2489-91. PubMed ID: 26809311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A Patient with Recurrent Ulcerative Colitis-Associated Rectal Cancer Attaining a Complete Response with FOLFIRI plus Bevacizumab].
    Iseki Y; Maeda K; Shibutani M; Nagahara H; Ikeya T; Tamura T; Ohira G; Sakurai K; Yamazoe S; Kimura K; Toyokawa T; Kubo N; Tanaka H; Muguruma K; Hirakawa K
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):2205-7. PubMed ID: 26805312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant capecitabine and oxaliplatin (XELOX) combined with bevacizumab for high-risk localized rectal cancer.
    Hasegawa J; Nishimura J; Mizushima T; Miyake Y; Kim HM; Takemoto H; Tamagawa H; Noura S; Fujii M; Fujie Y; Kato T; Miwa H; Takemasa I; Ikeda M; Yamamoto H; Sekimoto M; Nezu R; Doki Y; Mori M
    Cancer Chemother Pharmacol; 2014 May; 73(5):1079-87. PubMed ID: 24595805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effectiveness of Irinotecan, S-1, and Bevacizumab for Rectal Cancer with Lung and Skin Metastases after Adjuvant Chemotherapy].
    Hagihara K; Ikeda M; Maeda S; Uemura M; Yamamoto K; Miyake M; Hama N; Nishikawa K; Miyamoto A; Omiya H; Miyazaki M; Hirao M; Takami K; Nakamori S; Sekimoto M
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):2313-2315. PubMed ID: 28133306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of necrotizing fasciitis developed in a patient with recurrent rectal cancer treated with chemotherapy].
    Shimada A; Nakamura T; Ishii M; Chiba N; Ishikawa S; Arisawa Y; Hashimoto M
    Gan To Kagaku Ryoho; 2013 May; 40(5):663-5. PubMed ID: 23863596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy and safety of bevacizumab (BEV) plus chemotherapeutic agents in the treatment of metastatic colorectal cancer, mCRC].
    Guo X; Liu TS; Yu YY; Zhou YH; Chen Y; Zhuang RY; Cui YH
    Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):604-7. PubMed ID: 24314219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Phase I / II study of XELOX plus bevacizumab in Japanese patients with metastatic colorectal cancer(JO19380)].
    Sato A; Doi T; Boku N; Kato K; Komatsu Y; Yamaguchi K; Muro K; Hamamoto Y; Koizumi W; Mizunuma N; Takiuchi H
    Gan To Kagaku Ryoho; 2011 Apr; 38(4):561-9. PubMed ID: 21498982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A Case of Laparoscopic Surgery for Rectal Cancer with Synchronous Lung Metastases after Chemotherapy].
    Yoshida T; Morohashi H; Ichinohe D; Yoshida E; Okano K; Nagase H; Akasaka H; Jin H; Miura T; Sakamoto Y; Hakamada K
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):2320-2322. PubMed ID: 28133308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Two Cases of Metastatic Rectal Cancer Patients Who Received Chemotherapy with FOLFOXIRI plus Bevacizumab].
    Nishii T; Uchima Y; Yamakoshi Y; Wang E; Nagashima D; Hirakawa T; Aomatsu N; Iwauchi T; Morimoto J; Nakazawa K; Tei S; Takeuchi K
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):1705-1707. PubMed ID: 28133105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recurrent rectal cancer with multiple liver and lung metastases treated effectively with oxaliplatin and capecitabine plus bevacizumab chemotherapy-a case report].
    Yabe N; Murai S; Shimizu H; Kitasato K; Yoshikawa T; Oto I; Nakadai J; Hasegawa H; Kitagawa Y
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):1834-6. PubMed ID: 24393938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case in which chemotherapy-resistant sigmoid colon cancer was controlled effectively by radiotherapy and resection].
    Sato N; Mukubo H; Nakanuma S; Yasui T; Kita I; Takanaka T
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):1996-8. PubMed ID: 24393991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of pathological complete response with neoadjuvant XELOX chemotherapy for locally advanced rectal cancer].
    Kitahara T; Takemasa I; Inoue A; Osawa H; Miyo M; Mokutani Y; Ogawa H; Naito A; Hamabe A; Hiraki M; Munakata K; Uemura M; Nishimura J; Hata T; Mizushima T; Yamamoto H; Doki Y; Mori M
    Gan To Kagaku Ryoho; 2014 Nov; 41(12):1569-71. PubMed ID: 25731255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [XELOX plus Bevacizumab Chemotherapy for a Patient with Postoperative Recurrence of Colorectal Cancer Under Hemodialysis for Chronic Renal Failure].
    Takeda T; Miyake M; Tanaka K; Uemura M; Ikeda M; Maeda S; Yamamoto K; Hama N; Nishikawa K; Miyamoto A; Miyazaki M; Hirao M; Nakamori S; Sekimoto M
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):1594-6. PubMed ID: 26805107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case report of pathologically complete response of locally advanced rectal cancer after neoadjuvant chemoradiotherapy with XELOX and bevacizumab].
    Miyazawa T; Ebe K; Fujita N; Koide N; Honma K; Ikarashi T
    Gan To Kagaku Ryoho; 2012 Jun; 39(6):1001-3. PubMed ID: 22705702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Practical use of capecitabine plus oxaliplatin (CAPEOX) with bevacizumab for patients with metastatic colorectal cancer that cannot expect conversion therapy.
    Yokomizo H; Yoshimatsu K; Otani T; Osawa G; Nakayama M; Matsumoto A; Yano Y; Okayama S; Naritaka Y
    Hepatogastroenterology; 2013; 60(128):1911-5. PubMed ID: 24719926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Super-Elderly Patient with Recurrent Rectal Cancer with Liver Metastases Effectively Treated with Capecitabine plus Bevacizumab Chemotherapy--Report of a Case].
    Miyazaki Y; Miyazaki S; Fujita S; Hirose H; Sugimoto S; Michiura T; Yamabe K; Nagaoka M
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):2279-81. PubMed ID: 26805337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A Case of Rectal Cancer and Multiple Lung Metastases That Had Complete Response Treated by XELOX plus Bevacizumab after Primary Lesion Resection].
    Hiramatsu S; Sugimoto A; On O; Aomatsu K
    Gan To Kagaku Ryoho; 2022 Feb; 49(2):226-228. PubMed ID: 35249069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.